FDA Authorizes Pfizer’s COVID-19 Pill After Securing $5 Billion Deal With Federal Government

Click here to read the full article.

The Food and Drug Administration (FDA) on Wednesday granted emergency use authorization to Pfizer’s COVID-19 treatment pill.

The pill, Paxlovid, is taken twice per day for five days in combination with a second medicine called ritonavir, classified as a generic antiviral drug. The drug is aimed at helping patients who are suffering from “mild-to-moderate”  COVID-19 from becoming so sick that they need to be hospitalized, officials and Pfizer have said.

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally—a major step forward in the fight against this global pandemic,” Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said Wednesday in a news release about the agency’s approval.

Continue reading here.

Scroll down for comments and share what’s on your mind.


What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Procter and Gamble Voluntarily Recalls 32 Aerosol Hair Products Due to Cancer-Causing Chemical

First known ‘Omicron death in America’ in dispute—health official ‘can’t confirm’ cause of death